Request an appointmentat Mayo Clinic
Researchers find that a gene may play a role in causing people with telomere biology disorders to have a high risk of developing blood cancer.
Dr. Mohamed Kharfan Dabaja discusses who is eligible for CAR-T cell therapy, the treatment process and its potential side effects.
Hematologist Dr. Yi Lin discusses the use of immunotherapies and other novel approaches to treating multiple myeloma.
Dr. Reona Sakemura is researching treatment resistance mechanisms in multiple myeloma to make immunotherapy more effective.
Veronica Ciudad-Real shares her experience with multiple myeloma treatment as an international patient at Mayo Clinic.
Cancer experts have been exploring and improving multiple myeloma treatments that can extend periods of remission and enhance quality of life.
March is Multiple Myeloma Awareness Month. Here's what you should know about this relatively uncommon form of blood cancer.
Ann Arneson, diagnosed with multiple myeloma, is Mayo Clinic’s first bone marrow transplant patient to recover at home thanks to the new advanced care at home program.
Results of a study on smoldering multiple myeloma presented at the 2019 American Society of Clinical Oncology Annual Meeting suggest that the cancer drug lenalidomide ...
Researchers at Mayo Clinic have identified three specific gene types that account for a known twofold to threefold increase in myeloma diagnoses among African-Americans. Researchers ...